Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01920139 · ClinicalTrials.gov registry record · NA
Ultrasound Guided Core Biopsy vs Fine Needle Aspiration for Evaluation of Axillary Lymphadenopathy
A NA study of Focus: Breast Cancer With Axillary Node Metastasis, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
- 1
- Study location
NCT01920139 is a NA study of Focus: Breast Cancer With Axillary Node Metastasis that has completed, run by University of Pittsburgh. The registered enrollment target is 105 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01920139, a NA study of Focus: Breast Cancer With Axillary Node Metastasis, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
- 1
- Study location
Study Summary
The study was performed to determine if either ultrasound guided core biopsy or fine needle aspiration of an axillary lymph node has superior sensitivity in detecting metastatic carcinoma from the ipsilateral breast.
Conditions Studied
Interventions
- PROCEDURE Fine needle aspiration and core biopsy of lymph node
- PROCEDURE Axillary surgery
- OTHER Titanium marker
Study Locations (1)
Pennsylvania
- Magee Womens Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01920139
The ClinicalTrials.gov registry entry for NCT01920139 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Focus: Breast Cancer With Axillary Node Metastasis appearing as the primary indexed condition, and to 3 interventions - of which Fine needle aspiration and core biopsy of lymph node is the first listed.
NCT01920139 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01920139 about?
NCT01920139 is a clinical study titled "Ultrasound Guided Core Biopsy vs Fine Needle Aspiration for Evaluation of Axillary Lymphadenopathy". The study was performed to determine if either ultrasound guided core biopsy or fine needle aspiration of an axillary lymph node has superior sensitivity in detecting metastatic carcinoma from the ipsilateral breast.
What is the current status of trial NCT01920139?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2008-12. Estimated completion is 2011-06.
What conditions does trial NCT01920139 study?
This clinical trial studies the following conditions: Focus: Breast Cancer With Axillary Node Metastasis.
What interventions are being tested in trial NCT01920139?
The interventions under investigation include: Fine needle aspiration and core biopsy of lymph node (PROCEDURE), Axillary surgery (PROCEDURE), Titanium marker (OTHER).
Who is sponsoring clinical trial NCT01920139?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01920139 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.